Kurt Dobbelaere

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines · 2011 · 194 citations · Full text

Veterinary Medicine, Immunology, Oncology +13

Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study

Lynette Denny, Bronwyn Hendricks, Chivaugn Gordon et al. · Vaccine · 2013 · 104 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study

Aderonke Odutola, Martin O. C. Ota, Martín Antonio et al. · Vaccine · 2017 · 80 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study

Aderonke Odutola, MO Ota, EO Ogundare et al. · Human Vaccines & Immunotherapeutics · 2015 · 41 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years

Ryo Konno, Shinobu Tamura, Kurt Dobbelaere et al. · International Journal of Gynecological Cancer · 2010 · 41 citations

Life Sciences, Molecular Biology, Oncology +17